Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
暂无分享，去创建一个
E. Tartour | S. Sirima | F. Batteux | O. Launay | E. Remarque | C. Kocken | N. Benhamouda | S. Houard | S. Guéguen | C. Durier | L. Kara | A. Gansané | P. Loulergue | M. Bahuaud | I. Nébié | B. Faber | G. Sanou | I. Nebie’ | E. L. Pérez | E. Ouédraogo | K. Ammour